Hims & Hers Health’s Model ‘Proving Effective’: 2 Analysts Examine Q1 Earnings
2
0
Shares of Hims & Hers Health Inc (NYSE:HIMS) were climbing in early trading on Tuesday. The personal-care products company reported upbeat results for the first quarter.
The results be reported amid an exciting earnings season. Here are some key analyst expectations.
- Piper Sandler analyst Korinne Wolfmeyer maintained a Neutral rating, while raising the price target from $11 to $13.
- Truist Securities analyst Jailendra Singh reaffirmed a Hold rating and price target of $13.
Check out other analyst stock ratings.
Piper Sandler: Hims & Hers Health reported total revenue of $278.2 million. That represents 46% year-on-year growth and higher than Street expectations of $270.4 million, Wolfmeyer said in a note.
The San Francisco-based company also delivered a beat on adjusted EBITDA, “driven entirely …
Full story available on Benzinga.com
Visited 2 times, 1 visit(s) today